Relationship Study of The Verified Human Epidermal Growth Factor Receptor 2 Amplification with Other Tumor Markers and Clinicohistopathological Characteristics in Patients with Invasive Breast Cancer, Using Chromogenic In Situ Hybridization

OBJECTIVE: Human epidermal growth factor receptor 2 (HER-2), as a crucial factor involved in about 20% of breast cancer cases, is one of the most reliable tumor markers to determine prognosis and therapeutic trend of this disease. This marker is generally assessed by immunohistochemistry (IHC) techn...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarli, Abdolazim, Mozdarani, Hossein, Rakhshani, Nasser, Mozdarani, Sohail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royan Institute 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582419/
https://www.ncbi.nlm.nih.gov/pubmed/31210439
http://dx.doi.org/10.22074/cellj.2019.6219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582419/
https://www.ncbi.nlm.nih.gov/pubmed/31210439
http://dx.doi.org/10.22074/cellj.2019.6219

Ejemplares similares